Items where authors include "Huddart, R"
Up a levelArticle
Huddart, R, Hafeez, S, Lewis, R et al. (20 more authors) (2021) Clinical Outcomes of a Randomized Trial of Adaptive Plan-of-the-Day Treatment in Patients Receiving Ultra-hypofractionated Weekly Radiation Therapy for Bladder Cancer. International Journal of Radiation: Oncology - Biology - Physics, 110 (2). pp. 412-424. ISSN 0360-3016
Hafeez, S, Webster, A, Hansen, VN et al. (17 more authors) (2020) Protocol for tumour-focused dose-escalated adaptive radiotherapy for the radical treatment of bladder cancer in a multicentre phase II randomised controlled trial (RAIDER): radiotherapy planning and delivery guidance. BMJ Open, 10 (12). ARTN e041005. ISSN 2044-6055
Walsh, JS, Marshall, H orcid.org/0000-0003-0944-0152, Smith, IL et al. (9 more authors) (2019) Testosterone replacement in young male cancer survivors: A 6-month double-blind randomised placebo-controlled trial. PLOS Medicine, 16 (11). e1002960. ISSN 1549-1277
Litchfield, K, Loveday, C, Levy, M et al. (9 more authors) (2018) Large-scale Sequencing of Testicular Germ Cell Tumour (TGCT) Cases Excludes Major TGCT Predisposition Gene. European Urology, 73 (6). pp. 828-831. ISSN 0302-2838
Crabb, SJ, Martin, K, Abab, J et al. (21 more authors) (2017) COAST (Cisplatin ototoxicity attenuated by aspirin trial): A phase II double-blind, randomised controlled trial to establish if aspirin reduces cisplatin induced hearing-loss. European Journal of Cancer, 87. pp. 75-83. ISSN 0959-8049
Litchfield, K, Levy, M, Dudakia, D et al. (13 more authors) (2016) Rare disruptive mutations in ciliary function genes contribute to testicular cancer susceptibility. Nature Communications, 7. 13840. ISSN 2041-1723
Rapley, EA, Hockley, S, Warren, W et al. (36 more authors) (2004) Somatic mutations of KIT in familial testicular germ cell tumours. British Journal of Cancer, 90 (12). 2397 - 2401. ISSN 0007-0920
Conference or Workshop Item
Huddart, R, Hafeez, S, Omar, A et al. (22 more authors) (2021) Acute toxicity of hypo- and conventionally-fractionated radiosensitised bladder radiotherapy. In: ESTRO 2021, 28-31 Aug 2021, Madrid, Spain & Online.
Proceedings Paper
Hunt, A, Chan, A, Delacroix, L et al. (21 more authors) (2019) Establishing international variation in target delineation using MRI for bladder radiotherapy. In: Radiotherapy and Oncology. ESTRO 38, 26-30 Apr 2019, Milan, Italy. Elsevier BV , S857-S858.
Huddart, R, Henry, A orcid.org/0000-0002-5379-6618, Staffurth, J et al. (16 more authors) (2018) OC-0058: Clinical outcomes of the first rct of adaptive radiotherapy in bladder cancer (HYBRID CRUK/12/055). In: Radiotherapy and Oncology. ESTRO 37, 20-24 Apr 2018, Barcelona, Spain. Elsevier , S25-S26.